+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neogen Corp (NEOG) - Financial and Strategic SWOT Analysis Review

Neogen Corp (NEOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Neogen Corp (Neogen) develops, manufactures and markets various products related to food and animal safety. The company’s product portfolio includes diagnostic test kits to detect foodborne pathogens, natural toxins, spoilage organisms, food allergens, pesticide residues, genetic modifications, meat speciation, drug residues, ruminant by-products, animal safety, sanitation concerns and related products, pharmaceuticals, veterinary products, rodenticides, disinfectants, vaccines, topicals, cleaners, and insecticides. The company also offers genetic testing services for animal safety. Neogen markets its products through sales representatives, national and international distributors and large farm supply retail chains. Neogen and its subsidiaries operate across the world. Neogen is headquartered in Lansing, Michigan, the US.

Neogen Corp Key Recent Developments

  • Jul 30, 2024: Neogen Announces Fourth-Quarter 2024 Results
  • Jul 11, 2024: Neogen Announces Fourth-Quarter Earnings Release Date
  • Apr 09, 2024: Neogen Announces Third-Quarter 2024 Results
  • Mar 19, 2024: Neogen Announces Third-Quarter Earnings Release Date

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Neogen Corp - Key Facts
  • Neogen Corp - Key Employees
  • Neogen Corp - Key Employee Biographies
  • Neogen Corp - Major Products and Services
  • Neogen Corp - History
  • Neogen Corp - Company Statement
  • Neogen Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Neogen Corp - Business Description
  • Business Segment: Animal Safety
  • Overview
  • Performance
  • Business Segment: Food Safety
  • Overview
  • Performance
  • Geographical Segment: Domestic
  • Performance
  • Geographical Segment: International
  • Performance
  • R&D Overview
  • Neogen Corp - Corporate Strategy
  • Neogen Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Neogen Corp - Strengths
  • Neogen Corp - Weaknesses
  • Neogen Corp - Opportunities
  • Neogen Corp - Threats
  • Neogen Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Neogen Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Neogen Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Neogen Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 30, 2024: Neogen Announces Fourth-Quarter 2024 Results
  • Jul 11, 2024: Neogen Announces Fourth-Quarter Earnings Release Date
  • Apr 09, 2024: Neogen Announces Third-Quarter 2024 Results
  • Mar 19, 2024: Neogen Announces Third-Quarter Earnings Release Date
  • Feb 06, 2024: Neogen Announces James Walter as Vice President, Global Operations
  • Jan 09, 2024: Neogen Announces Second-Quarter 2024 Results
  • Oct 10, 2023: Neogen Announces First-Quarter 2024 Results
  • Aug 30, 2023: Neogen wins best innovative luminol-based substrate award
  • Jul 27, 2023: Neogen Announces Fourth-Quarter 2023 Results
  • Jul 11, 2023: Neogen Announces Fourth-Quarter Earnings Release Date
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Neogen Corp, Key Facts
  • Neogen Corp, Key Employees
  • Neogen Corp, Key Employee Biographies
  • Neogen Corp, Major Products and Services
  • Neogen Corp, History
  • Neogen Corp, Subsidiaries
  • Neogen Corp, Key Competitors
  • Neogen Corp, Ratios based on current share price
  • Neogen Corp, Annual Ratios
  • Neogen Corp, Interim Ratios
  • Neogen Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Neogen Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Neogen Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Neogen Corp, Performance Chart (2020 - 2024)
  • Neogen Corp, Ratio Charts
  • Neogen Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Neogen Corp, Medical Equipment, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Merial Ltd
  • Monogram Biosciences Inc
  • Elanco Animal Health Inc
  • Idexx Laboratories Inc
  • LGC Clinical Diagnostics Inc